Fill out the form below and we'll send your colleague an invitation to the "Enabling Continuous Bioprocessing With Multi-Column Chromatography" event. As biopharmaceutical manufacturers move toward ...
WALTHAM, Mass., Dec. 09, 2024 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today announced the launch of AVIPure ® ...
Repligen Conference: CEO touts differentiated bioprocessing portfolio; CFO targets 30% EBITDA margin
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
Breakthrough Innovation for the Purification of mRNA Therapeutics and Vaccines WALTHAM, Mass., Dec. 09, 2024 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results